S&P 500   4,549.34 (-0.39%)
DOW   36,054.43 (-0.19%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.81 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.00 (-2.29%)
NIO   7.75 (+4.31%)
BABA   71.49 (-1.23%)
AMD   116.82 (-1.32%)
T   16.94 (-1.63%)
F   10.69 (+0.85%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.70%)
GE   119.81 (-0.35%)
DIS   91.50 (+0.78%)
AMC   6.79 (-3.28%)
PFE   28.79 (-1.03%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)
S&P 500   4,549.34 (-0.39%)
DOW   36,054.43 (-0.19%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.81 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.00 (-2.29%)
NIO   7.75 (+4.31%)
BABA   71.49 (-1.23%)
AMD   116.82 (-1.32%)
T   16.94 (-1.63%)
F   10.69 (+0.85%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.70%)
GE   119.81 (-0.35%)
DIS   91.50 (+0.78%)
AMC   6.79 (-3.28%)
PFE   28.79 (-1.03%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)
S&P 500   4,549.34 (-0.39%)
DOW   36,054.43 (-0.19%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.81 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.00 (-2.29%)
NIO   7.75 (+4.31%)
BABA   71.49 (-1.23%)
AMD   116.82 (-1.32%)
T   16.94 (-1.63%)
F   10.69 (+0.85%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.70%)
GE   119.81 (-0.35%)
DIS   91.50 (+0.78%)
AMC   6.79 (-3.28%)
PFE   28.79 (-1.03%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)
S&P 500   4,549.34 (-0.39%)
DOW   36,054.43 (-0.19%)
QQQ   385.05 (-0.58%)
AAPL   192.32 (-0.57%)
MSFT   368.81 (-1.00%)
META   317.45 (-0.26%)
GOOGL   130.02 (-0.74%)
AMZN   144.52 (-1.61%)
TSLA   239.37 (+0.27%)
NVDA   455.00 (-2.29%)
NIO   7.75 (+4.31%)
BABA   71.49 (-1.23%)
AMD   116.82 (-1.32%)
T   16.94 (-1.63%)
F   10.69 (+0.85%)
MU   73.13 (-0.76%)
CGC   0.70 (+4.70%)
GE   119.81 (-0.35%)
DIS   91.50 (+0.78%)
AMC   6.79 (-3.28%)
PFE   28.79 (-1.03%)
PYPL   59.53 (+2.78%)
XOM   99.11 (-1.32%)

Chemours Stock Price, News & Analysis (NYSE:CC)

$28.79
+0.06 (+0.21%)
(As of 04:00 PM ET)
Compare
Today's Range
$28.57
▼
$29.68
50-Day Range
$23.59
▼
$29.69
52-Week Range
$22.88
▼
$39.05
Volume
857,316 shs
Average Volume
1.26 million shs
Market Capitalization
$4.27 billion
P/E Ratio
N/A
Dividend Yield
3.47%
Price Target
$33.10
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Chemours MarketRank™ Stock Analysis

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
14.4% Upside
$33.10 Price Target
Short Interest
Healthy
3.69% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.29mentions of Chemours in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
21.45%
From $2.89 to $3.51 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.59 out of 5 stars

Basic Materials Sector

36th out of 176 stocks

Chemicals & Allied Products Industry

5th out of 15 stocks

See Top Rated MarketRank™ Stocks Here

CC stock logo

About Chemours Stock (NYSE:CC)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

CC Stock Price History

CC Stock News Headlines

December 5, 2023 | finance.yahoo.com
PEM Membrane Technologies and the New Hydrogen Economy
December 3, 2023 | americanbankingnews.com
Chemours (NYSE:CC) Rating Increased to Outperform at Royal Bank of Canada
December 6, 2023 | Edge On The Street (Ad)
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
December 3, 2023 | americanbankingnews.com
Chemours (NYSE:CC) Shares Gap Up to $27.43
December 1, 2023 | msn.com
RBC Capital Upgrades Chemours (CC)
December 1, 2023 | za.investing.com
Chemours lifted at RBC Capital on TiO2 margin recovery
December 1, 2023 | msn.com
Chemours upgraded to Outperform at RBC Capital
November 30, 2023 | msn.com
New Hanover County commissioners react to EPA reversing approval of Chemours’ plan to import Genx waste from overseas
December 6, 2023 | Financial Alphas (Ad)
Lithium Discovery So BIG You Can't Miss it, Even From Space
With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!
November 29, 2023 | finanznachrichten.de
The Chemours Company: Chemours Establishes International F-Gas Lifecycle Program To Advance Global Circularity
November 29, 2023 | yahoo.com
UN officials accuse Chemours, DuPont, regulators of human rights violations over PFAS
November 29, 2023 | finance.yahoo.com
Chemours Announces Settlement Agreement with State of Ohio
November 28, 2023 | msn.com
PFAS's Forever Problem: Ohio Lawsuit Against Chemical Companies Fizzles Out
November 28, 2023 | finance.yahoo.com
Chemours Establishes International F-gas Lifecycle Program to Advance Global Circularity
November 27, 2023 | finance.yahoo.com
2023 Top Women in HVAC: Christina Spalding
November 24, 2023 | finance.yahoo.com
One Chemours Insider Raised Their Stake In The Previous Year
November 22, 2023 | finance.yahoo.com
The Chemours Company Announces Changes to its Board of Directors
November 20, 2023 | markets.businessinsider.com
Analysts Offer Insights on Materials Companies: Chemours Company (CC), Osisko Gold Royalties (OR) and Compass Minerals International (CMP)
November 20, 2023 | finanznachrichten.de
The Chemours Company: How Chemours' Chemistries Are Helping To Sustainably Scale the Hydrogen Economy
November 20, 2023 | finance.yahoo.com
How Chemours’ Chemistries Are Helping To Sustainably Scale the Hydrogen Economy
November 17, 2023 | msn.com
Protest planned at Fayetteville Chemours plant in spite of pause to GenX imports
November 15, 2023 | finance.yahoo.com
Chemours (CC) Boosts Low GWP HFC-152a Production by 20%
November 14, 2023 | msn.com
Chemours jumps on plans to raise capacity of HFC-152a chemical at Texas plant
November 14, 2023 | finance.yahoo.com
Chemours Announces Capacity Increase of HFC-152a, Providing Reliable, Domestic Supply of Low Global Warming Potential Solution
November 10, 2023 | msn.com
Gov. Cooper, New Hanover Co. commissioners send letters to EPA over PFAS concerns
November 9, 2023 | finance.yahoo.com
Chemours Chief Sustainability Officer’s Takeaways From Financial Times’ Event on Navigating the Complexities of Scope 3 Reporting
November 6, 2023 | finance.yahoo.com
Chemours CEO Visits Sustainable Mining Operation in Georgia
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 9/15 Dividend
8/14/2023
Dividend Payable
9/15/2023
Last Earnings
10/26/2023
Ex-Dividend for 12/15 Dividend
11/14/2023
Today
12/06/2023
Dividend Payable
12/15/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/08/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Chemicals & allied products
Sub-Industry
N/A
Sector
Basic Materials
Current Symbol
NYSE:CC
CUSIP
N/A
CIK
1627223
Web
www.chemours.com
Phone
(302) 773-1000
Fax
N/A
Employees
6,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$33.10
High Stock Price Target
$43.00
Low Stock Price Target
$25.00
Potential Upside/Downside
+14.4%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
10 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($2.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
10.01
P/E Growth
N/A
Net Income
$578 million
Net Margins
-5.13%
Pretax Margin
-5.10%
Return on Equity
42.13%
Return on Assets
5.33%

Debt

Debt-to-Equity Ratio
5.21
Current Ratio
1.68
Quick Ratio
1.08

Sales & Book Value

Annual Sales
$6.79 billion
Price / Sales
0.63
Cash Flow
$6.70 per share
Price / Cash Flow
4.32
Book Value
$7.34 per share
Price / Book
3.94

Miscellaneous

Outstanding Shares
148,440,000
Free Float
146,018,000
Market Cap
$4.30 billion
Optionable
Optionable
Beta
2.00
Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report














CC Stock Analysis - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings or view top-rated stocks.

What is Chemours' stock price target for 2024?

10 analysts have issued twelve-month price objectives for Chemours' stock. Their CC share price targets range from $25.00 to $43.00. On average, they predict the company's stock price to reach $33.10 in the next year. This suggests a possible upside of 14.4% from the stock's current price.
View analysts price targets for CC or view top-rated stocks among Wall Street analysts.

How have CC shares performed in 2023?

Chemours' stock was trading at $30.62 at the beginning of 2023. Since then, CC stock has decreased by 5.5% and is now trading at $28.94.
View the best growth stocks for 2023 here.

Are investors shorting Chemours?

Chemours saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 5,410,000 shares, a drop of 6.6% from the October 31st total of 5,790,000 shares. Based on an average daily trading volume, of 1,190,000 shares, the days-to-cover ratio is presently 4.5 days. Currently, 3.7% of the shares of the company are sold short.
View Chemours' Short Interest.

When is Chemours' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our CC earnings forecast.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) posted its quarterly earnings results on Thursday, October, 26th. The specialty chemicals company reported $0.64 earnings per share for the quarter, missing the consensus estimate of $0.77 by $0.13. The specialty chemicals company earned $1.49 billion during the quarter, compared to analyst estimates of $1.54 billion. Chemours had a negative net margin of 5.13% and a positive trailing twelve-month return on equity of 42.13%.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Thursday, October 26th. Investors of record on Wednesday, November 15th will be given a dividend of $0.25 per share on Friday, December 15th. This represents a $1.00 annualized dividend and a yield of 3.46%. The ex-dividend date of this dividend is Tuesday, November 14th.
Read our dividend analysis for CC.

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.37%.
Read our dividend analysis for CC.

What ETFs hold Chemours' stock?

ETFs with the largest weight of Chemours (NYSE:CC) stock in their portfolio include First Trust Materials AlphaDEX Fund (FXZ), First Trust Dorsey Wright Momentum & Dividend ETF (DDIV), Invesco Dorsey Wright Basic Materials Momentum ETF (PYZ), First Trust Dorsey Wright Momentum & Value ETF (DVLU), JPMorgan Active Value ETF (JAVA), Fidelity Small-Mid Cap Opportunities ETF (FSMO), iShares U.S. Basic Materials ETF (IYM) and Avantis U.S. Small Cap Value ETF (AVUV).

What guidance has Chemours issued on next quarter's earnings?

Chemours issued an update on its FY 2023 earnings guidance on Friday, October, 27th. The company provided earnings per share guidance of $2.77-$3.00 for the period, compared to the consensus earnings per share estimate of $3.35. The company issued revenue guidance of -.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

Who are Chemours' major shareholders?

Chemours' stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (11.75%), Bank of New York Mellon Corp (4.18%), Massachusetts Financial Services Co. MA (2.13%), LSV Asset Management (1.75%), Ameriprise Financial Inc. (1.74%) and Deutsche Bank AG (1.19%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Matthew S Abbott and Sameer Ralhan.
View institutional ownership trends.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:CC) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -